Latest News and Press Releases
Want to stay updated on the latest news?
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 09, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fate Therapeutics, Inc...
-
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares...
-
SAN DIEGO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares...
-
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired...
-
SAN DIEGO, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired shares...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fate Therapeutics, Inc...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 22, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fate Therapeutics Inc. (“Fate”...